Health-care companies rose, but not by as much as the broad market, amid mixed earnings reports.

Shares of drug-store chain and insurer CVS Health fell after it cut growth estimates for the third consecutive quarter.

IQVIA Holdings shares slipped after the provider of services to life-sciences companies cut its 2023 revenue target, as it anticipated a strong rate of sales growth to falter somewhat at the year's end.

Aldeyra Therapeutics shares surged after drug giant AbbVie secured an option to license an eye-condition drug from the development-stage biotech company.

Write to Rob Curran at

(END) Dow Jones Newswires

11-01-23 1801ET